BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2011
View Archived Issues
Germline SNPs inked to outcome of docetaxel-treated metastatic castration-resistant prostate cancer
Read More
Soluble CD276 antigen in expressed prostatic secretions is a biomarker of chronic prostatitis
Read More
RITA has synergistic activity with chemotherapeutic agents in MM cells in vitro
Read More
Regeneron reports new phase III data on Arcalyst for prevention of gout flares
Read More
New modified sesamol derivative INV-403 suppresses atherosclerosis in vivo
Read More
Nile Therapeutics and Medtronic collaborate on development of cenderitide
Read More
New phase II trial evaluates Prostvac with docetaxel in prostate cancer
Read More
New inhibitors of cGMP-specific 3',5'-cyclic phosphodiesterase claimed
Read More
Pfizer completes acquisition of King Pharmaceuticals
Read More
New inhibitors patented of enoyl-[acyl-carrier-protein] reductase [NADH]
Read More
Kyorin and Almirall sign license agreement for aclidinium bromide in Japan
Read More
Daiichi Sankyo to acquire Plexxikon
Read More
Medivir's Xerese launched in the U.S. as prescription cold sore treatment
Read More
FDA grants Epeius' anticancer gene therapy Rexin-G phase III status
Read More
Mochida Pharma requests Japanese approval for Beselna in solar keratoses
Read More
Novartis seeks approval in Japan for Certican to prevent renal transplant rejection
Read More
Gemzar approved in Japan for ovarian cancer after chemotherapy
Read More
Novavax receives contract to develop flu vaccines for U.S. government
Read More
Seattle Genetics and Millennium begin phase I trial of brentuximab vedotin
Read More
Oxygen Biotherapeutics receives grant from U.S. army to study Oxycyte in traumatic brain injury
Read More
NPS Pharma advances pivotal REPLACE trial of NPSP-558 in hypoparathyroidism
Read More
European approval for Xiapex for Dupuytren's contracture
Read More
HIV reverse transcriptase inhibitors patented by AiCuris
Read More
Novel inhibitors of 11-beta-HSD1 presented
Read More
Selexagen discloses new sonic hedgehog protein inhibitors
Read More
